The pharmaceutical giant narrowed its full-year guidance after its blockbuster Wegovy weight-loss drug beat sales expectations in the third quarter.
Source link
What’s your Reaction?
+1
+1
+1
+1
Novo Nordisk’s Wegovy Sales Beat Expectations – Daily Frontline
